AVBP
ArriVent BioPharma, Inc.
28.30$
-2.3%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +47.0% | +95.9% | +22.4% | +13.2% | +9.9% | +138.6% | +45.8% | +12.2% | -13.3% | +70.2% | +21.5% | – | |
| – | – | -130.8% | – | +65.8% | +5.2% | -267.0% | – | -331.0% | – | -174.6% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | -62.2% | -464.9% | +40.3% | – | +1,186.2% | – | |
| – | +2.3% | – | -99.8% | +46.3% | -89.6% | +12,189.1% | +1,011.3% | +15.1% | -59.8% | +58.0% | +56.9% | – | |
| – | – | +1,749.4% | -111.2% | – | – | – | – | -100.1% | – | – | +459.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.